Your institution may have access to this item. Find your institution then sign in to continue.
Title
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.
Authors
Kulke MH; Demetri GD; Sharpless NE; Ryan DP; Shivdasani R; Clark JS; Spiegelman BM; Kim H; Mayer RJ; Fuchs CS; Kulke, Matthew H; Demetri, George D; Sharpless, Norman E; Ryan, David P; Shivdasani, Ramesh; Clark, Jeffrey S; Spiegelman, Bruce M; Kim, Haesook; Mayer, Robert J; Fuchs, Charles S